Domestic brokerage firm Axis Direct has pegged the Nifty target for December 2026 at 29,480, implying a 30% upside from current levels. Indian equities have underperformed the US market and other emerging markets by a notable margin in 2025, leading to a meaningful moderation in valuations. The brokerage is bullish on nine largecap stocks that have the potential to rally up to 57%. Here is the full list.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026